07/12/12Amarin shares plunge on decision to hire own sales force for Vascepa launch
14/11/11Amarin to present positive results from two phase 3 studies of anti-triglyceride drug
26/09/11Amarin submits NDA for triglyceride-lowering AMR101 drug
18/04/11Amarin shares surge on phase III results of triglyceride-lowering drug
Recent Sector News
Bedrocan Cannabis (CVE:BED), which recently received a marijuana producer's license for its 52,000 square foot facility in the GTA, has established a patient advisory board and appointed one of the founders of Canada's first ever compassion club as director of patient and community services.
Bacterin International (NYSEMKT:BONE) is one of the top four players in the $410 million U.S. demineralized bone matrix (DBM) market, with over 6 percent market share, said analysts at H.C. Wainwright (HCW) on Tuesday.
Pressure BioSciences (OTCMKTS:PBIO) is in for a terrific year, according to chief executive officer Richard Schumacher, who spoke in a recent video interview with StockNewsNow.com which was published today.
Under the terms of the license, effective February 17 for a period of one year, Bedrocan can begin domestic production in the first six grow rooms at its new 52,000 square foot facility in the Greater Toronto Area, with first production harvest and sale slated for the second quarter.
Pressure BioSciences receives $1 mln grant from NIH to develop sample preparation platform for NGS system
Pressure BioSciences (OTCQB:PBIO) has been awarded an over $1 million, phase II grant from the National Institutes of Health (NIH), which will help fund the development of an automated, high throughput, high pressure system to better control DNA fragmentation, the company said.
Oncolytics Biotech (TSE:ONC) (NASDAQ:ONCY) surged more than 30 percent after the clinical-stage biotech company said its lead product candidate, Reolysin, has been granted orphan drug designation for the treatment of pancreatic cancer by the U.S. FDA.
Investors interested in Amarin recently viewed
- Consegna Group (ASX: CGP) A vehicle to the China & North Asian pharmaceutical markets
- African Medical Investments (AIM: AMEI) Capital Appreciation through Private Healthcare in Africa
- HealthLinx (ASX: HTX) HealthLinx will be recognised as a leader in delivering diagnostic applicat
- Regeneus Limited (ASX: RGS) .
- SomnoMed (ASX: SOM) .